Alliance Wealth Advisors (Pennsylvania)’s GSK GSK Stock Holding History

Alliance Wealth Advisors (Pennsylvania)’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$437K	Sell	8,329 -744	-8%	-$39.3K	0.14%	99
2026 Q1	$501K	Sell	9,073 -302	-3%	-$16.4K	0.22%	76
2025 Q4	$460K	Buy	9,375 +61	+0.7%	+$2.85K	0.2%	83
2025 Q3	$402K	Buy	9,314 +74	+0.8%	+$2.89K	0.18%	97
2025 Q2	$355K	Buy	9,240 +65	+0.7%	+$2.48K	0.18%	105
2025 Q1	$355K	Buy	9,175 +257	+3%	+$9.41K	0.2%	94
2024 Q4	$302K	Buy	8,918 +1,688	+23%	+$60.8K	0.17%	111
2024 Q3	$296K	Sell	7,230 -6	-0.1%	-$245	0.17%	115
2024 Q2	$279K	Sell	7,236 -69	-0.9%	-$2.9K	0.18%	110
2024 Q1	$313K	Sell	7,305 -56	-0.8%	-$2.31K	0.2%	103
2023 Q4	$273K	Sell	7,361 -506	-6%	-$18.2K	0.18%	107
2023 Q3	$285K	Buy	+7,867	New	+$279K	0.21%	95

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Alliance Wealth Advisors (Pennsylvania)'s GSK Position: Q2 2026 in Review

Alliance Wealth Advisors (Pennsylvania) reduced its GSK (GSK) stake by 8.2% in Q2 2026, selling an estimated $39.3K and leaving 8,329 shares worth $437K. The position accounts for 0.14% of the portfolio, ranked #99.

Alliance Wealth Advisors (Pennsylvania) first reported a position in GSK in Q3 2023 and has held it in 12 quarters since. The position peaked at $501K in Q1 2026. 1,042 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Alliance Wealth Advisors (Pennsylvania) held 8,329 shares of GSK worth $437K as of Q2 2026.
Alliance Wealth Advisors (Pennsylvania) sold 744 GSK shares in Q2 2026, an estimated $39.3K.
GSK made up 0.14% of Alliance Wealth Advisors (Pennsylvania)'s portfolio in Q2 2026, its #99 holding.
Alliance Wealth Advisors (Pennsylvania) first reported a position in GSK in Q3 2023 and has held it in 12 quarters since.
Alliance Wealth Advisors (Pennsylvania)'s GSK position peaked at $501K in Q1 2026.
1,042 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Alliance Wealth Advisors (Pennsylvania)'s 13F filing for Q2 2026, filed 9 Jul 2026.